Here's the live share price of Vivanza Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Vivanza Biosciences has declined 25.71% CAGR. Over the past year, the corresponding return has been -43.53%.
Vivanza Biosciences’s current P/E of -26.90x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Vivanza Biosciences | 0 | -13.14 | -1.44 | -4.65 | -43.53 | -47.91 | -25.71 |
| Sun Pharmaceutical Industries | -3.37 | -0.78 | 5.89 | 5.97 | -3.02 | 20.90 | 24.86 |
| Divi's Laboratories | -0.68 | -1.34 | 4.69 | -2.29 | 9.24 | 24.04 | 10.77 |
| Torrent Pharmaceuticals | -0.94 | -0.73 | 5.57 | 16.70 | 11.39 | 33.11 | 22.12 |
| Cipla | -0.96 | -1.13 | -5.12 | -0.05 | 1.73 | 10.95 | 13.53 |
| Dr. Reddy's Laboratories | 0.26 | 2.63 | -3.49 | -2.78 | 0.09 | 13.21 | 4.06 |
| Lupin | 1.86 | 3.51 | 3.57 | 8.46 | 0.97 | 42.74 | 16.86 |
| Zydus Lifesciences | -1.35 | -1.97 | -13.16 | -4.99 | -7.06 | 30.52 | 13.82 |
| Mankind Pharma | -1.46 | -4.00 | -19.07 | -9.31 | -23.90 | 14.45 | 8.44 |
| Aurobindo Pharma | 3.28 | -2.30 | 7.31 | 9.39 | -2.95 | 40.38 | 6.45 |
| Alkem Laboratories | -2.10 | -3.58 | 0.51 | 14.62 | 0.39 | 22.43 | 13.24 |
| Abbott India | -1.27 | -6.14 | -9.87 | -11.54 | -0.94 | 10.11 | 11.52 |
| Glenmark Pharmaceuticals | -0.05 | 6.17 | -7.33 | 17.78 | 28.29 | 67.47 | 30.53 |
| Laurus Labs | -0.22 | 0.98 | 10.07 | 53.14 | 79.08 | 37.85 | 23.47 |
| Biocon | 2.56 | -7.19 | 6.23 | 14.37 | 12.46 | 14.16 | -3.66 |
| GlaxoSmithKline Pharmaceuticals | -3.21 | 2.09 | -7.63 | -22.68 | 8.77 | 24.02 | 9.53 |
| Anthem Biosciences | -1.47 | 2.40 | -21.05 | -7.58 | -7.58 | -2.59 | -1.56 |
| Ipca Laboratories | -3.52 | -0.35 | 6.01 | 4.11 | -6.44 | 18.41 | 4.91 |
| Ajanta Pharma | -1.71 | 5.89 | 2.29 | 0.97 | -9.93 | 30.31 | 18.84 |
| J B Chemicals & Pharmaceuticals | -1.37 | -0.53 | 5.82 | 4.08 | -3.60 | 20.22 | 27.44 |
Over the last one year, Vivanza Biosciences has declined 43.53% compared to peers like Sun Pharmaceutical Industries (-3.02%), Divi's Laboratories (9.24%), Torrent Pharmaceuticals (11.39%). From a 5 year perspective, Vivanza Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (24.86%) and Divi's Laboratories (10.77%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 2.09 | 2.09 |
| 10 | 2.12 | 2.12 |
| 20 | 2.2 | 2.15 |
| 50 | 2.12 | 2.14 |
| 100 | 2.1 | 2.16 |
| 200 | 2.18 | 2.47 |
In the latest quarter, Vivanza Biosciences remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 79.98% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Dec 17, 2025, 11:31 PM IST | Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Dec 17, 2025, 11:28 PM IST | Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot |
| Dec 04, 2025, 10:08 PM IST | Vivanza Biosciences - Reg. 34 (1) Annual Report. |
| Nov 14, 2025, 9:18 PM IST | Vivanza Biosciences - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| Nov 14, 2025, 6:37 PM IST | Vivanza Biosciences - Results - Financial Results For 30Th September, 2025 |
Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 2.94 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vivanza Biosciences is ₹2.05 as on Dec 18, 2025.
The Vivanza Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Vivanza Biosciences is ₹8.20 Cr as on Dec 18, 2025.
Today’s highest and lowest price of Vivanza Biosciences are ₹2.13 and ₹2.04.
The 52-week high/low is the highest and lowest price at which Vivanza Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Vivanza Biosciences is ₹3.95 and 52-week low of Vivanza Biosciences is ₹1.90 as on Dec 18, 2025.
The Vivanza Biosciences has shown returns of 0.99% over the past day, -13.14% for the past month, -1.44% over 3 months, -43.53% over 1 year, -47.91% across 3 years, and -25.71% over 5 years.
P/E ratio of and PB ratio of Vivanza Biosciences are -26.90 and 1.67 on Dec 18, 2025. While the company gives a dividend yield of 0.00 per annum.